Anchora Medical Overview
Anchora Medical is developing minimal invasive suturing devices for both endoscopic (GI) and laparoscopic (hernia) procedures. The devices are sterile, automatic, single-use suturing device for the approximation or fixation of soft tissue during minimally invasive surgeries. The device incorporates tiny stainless steel or nitinol anchors threaded on a surgical thread to create either running or interrupted sutures in the tissue. In July 2021, Anchora Medical received FDA clearance for its 1st product; Su2ura Approximation Device. The device is in clinical use.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Anchora Medical Receives FDA clearance for its Su2ura® Minimally-Invasive Surgical Suturing Device
Anchora Medical, an Israel-based medical device company, has received FDA clearance for its Su2ura® Approximation Device, an innovative automated suturing device used in laparoscopic surgery. The device simplifies the suturing procedure, aiming to shorten operation time, lower costs, reduce risks, and improve clinical outcomes. The FDA clearance is a critical milestone for Anchoras development and will enable the company to move forward with commercialization. Among Anchoras investors are HOYA Corporation, Dr. Shimon Eckhouse, Alon Medtech Ventures, Tal Capital, and other private investors.
Customers
growth-positive
Anchora Medical announces closing of a $4.5M financing round led by HOYA Corporation
Anchora Medical, a portfolio company of Alon Medtech Ventures, has closed a $4.5 million financing round led by HOYA Corporation and Tal Capital. The funds will be used to complete Anchoras family of single-use laparoscopic suturing devices. The partnership with HOYA is seen as a validation of Anchoras technology and will help the company move towards commercialization. HOYAs leadership position in the global minimally-invasive surgical market is expected to play a critical role in bringing Anchoras technology to surgeons and patients worldwide. Timothy Gehlmann, President and CEO of HOYAs Microline Surgical division, has joined Anchora as a board member. The investment further complements HOYAs aim of partnering with innovative minimally-invasive surgical companies. The event described in the article took place on February 26, 2020.
Investment
growth-positive
Anchora Medical announced winner of the i3 summit shark tank competition at the 2018 SAGES - Alon MedTech
Anchroa Medical has won the i3 summit shark tank competition at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). They are developing a disruptive surgical sewing machine for Minimally Invasive Surgery (MIS) with a focus on hernia treatment and prevention. The companys innovative ideas and products were showcased at the forum.
PartnersCustomers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $5.2M |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 3 |
| Investors | 5 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | anchora-medical.com |
Locations
Leshem St 1, Caesarea, 3079820, Israel
Photos & Videos
5 item(s)
